photo of Dr Nicole Messina

Dr Nicole Messina

Dr Nicole Messina

Details

Role Team Leader / Senior Research Officer

Contact

Available for student supervision
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the Peter MacCallum Cancer Centre investigating crosstalk in cytokine signalling pathways and the role of interferon signalling pathways in tumour immunosurveillance. Her previous research has also included investigating the role of cytokine response pathways in regulatory T cell development and function. Dr Messina co-supervises four PhD students, holds an Honorary Research Fellow appointment with the University of Melbourne and is a member of the Melbourne Children's Graduate Research Committee and MCRI animal ethics committee.
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the...
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the Peter MacCallum Cancer Centre investigating crosstalk in cytokine signalling pathways and the role of interferon signalling pathways in tumour immunosurveillance. Her previous research has also included investigating the role of cytokine response pathways in regulatory T cell development and function. Dr Messina co-supervises four PhD students, holds an Honorary Research Fellow appointment with the University of Melbourne and is a member of the Melbourne Children's Graduate Research Committee and MCRI animal ethics committee.

Top Publications

  • Villanueva, P, Wadia, U, Crawford, NW, Messina, NL, Kollmann, TR, Lucas, M, Manning, L, Richmond, P, Pittet, LF, Curtis, N. The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines. PLOS ONE 17(6) : e0268042 2022
    view publication
  • Pittet, LF, Fritschi, N, Tebruegge, M, Dutta, B, Donath, S, Messina, NL, Casalaz, D, Hanekom, WA, Britton, WJ, Robins-Browne, R, et al. Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Post Hoc Analysis of a Randomized Controlled Trial.. American Journal of Respiratory and Critical Care Medicine 205(7) : 830 -841 2022
    view publication
  • Pittet, LF, Messina, NL, Gardiner, K, Freyne, B, Abruzzo, V, Morrison, C, Vuillermin, P, Allen, KJ, Ponsonby, A-L, Robins-Browne, R, et al. Discordance Between Diagnosis Tools for Assessing Eczema in Infants: A Challenge for Intervention Trials. Dermatitis 33(3) : 207 -214 2022
    view publication
  • Pittet, LF, Cox, L, Freyne, B, Germano, S, Bonnici, R, Gardiner, K, Donath, S, Collins, CL, Casalaz, D, Robins-Browne, R, et al. Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner. Vaccine 40(9) : 1334 -1341 2022
    view publication
  • Villanueva, P, Wadia, U, Crawford, N, Messina, NL, Kollmann, TR, Lucas, M, Manning, L, Richmond, P, Pittet, LF, Curtis, N. Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy. npj Vaccines 7(1) : 6 2022
    view publication

Page 1 of 9

Professional activities